Groupama Asset Managment »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2023-12-31 $814k 800k 1.02

More positions owned by Groupama Asset Managment

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
UnitedHealth (UNH)
NVIDIA Corporation (NVDA)
Motorola Solutions Com New (MSI)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Parker-Hannifin Corporation (PH)
Thermo Fisher Scientific (TMO)
Regeneron Pharmaceuticals (REGN)
Tesla Motors (TSLA)

View all positions for Groupama Asset Managment

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Capstone Investment Advisors
Weiss Asset Management LP[1

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1